Sigachi Industries Limited (SIGACHI.BO)
INR 52.77
(2.73%)
INR 52.77
(2.73%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 3.98 Billion INR | 32.08% |
| 2022 | 3.02 Billion INR | 20.68% |
| 2021 | 2.5 Billion INR | 29.85% |
| 2020 | 1.92 Billion INR | 38.61% |
| 2019 | 1.39 Billion INR | 7.81% |
| 2018 | 1.28 Billion INR | 25.54% |
| 2017 | 1.02 Billion INR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 957.12 Million INR | -8.08% |
| 2023 Q3 | 1.1 Billion INR | 11.87% |
| 2023 Q2 | 991.77 Million INR | 17.09% |
| 2023 Q4 | 1.04 Billion INR | -6.15% |
| 2023 Q1 | 847.03 Million INR | 16.96% |
| 2023 FY | 3.98 Billion INR | 32.08% |
| 2022 Q4 | 724.19 Million INR | 5.19% |
| 2022 Q3 | 688.46 Million INR | -16.52% |
| 2022 Q2 | 824.67 Million INR | 5.31% |
| 2022 Q1 | 783.11 Million INR | 7.95% |
| 2022 FY | 3.02 Billion INR | 20.68% |
| 2021 Q2 | 571.96 Million INR | 4.08% |
| 2021 FY | 2.5 Billion INR | 29.85% |
| 2021 Q4 | 725.47 Million INR | 10.6% |
| 2021 Q3 | 655.92 Million INR | 14.68% |
| 2021 Q1 | 549.53 Million INR | 6.24% |
| 2020 FY | 1.92 Billion INR | 38.61% |
| 2020 Q3 | 483 Million INR | -1.31% |
| 2020 Q2 | 489.42 Million INR | 11.77% |
| 2020 Q1 | 437.88 Million INR | 0.0% |
| 2020 Q4 | 517.24 Million INR | 7.09% |
| 2019 FY | 1.39 Billion INR | 7.81% |
| 2018 FY | 1.28 Billion INR | 25.54% |
| 2017 FY | 1.02 Billion INR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Ajanta Pharma Limited | 42.08 Billion INR | 90.521% |
| Amrutanjan Health Care Limited | 4.21 Billion INR | 5.288% |
| Bal Pharma Limited | 3.39 Billion INR | -17.61% |
| Ind-Swift Laboratories Limited | 12.8 Billion INR | 68.853% |
| Medico Remedies Limited | 1.44 Billion INR | -175.293% |
| Lasa Supergenerics Limited | 1.04 Billion INR | -282.38% |
| Venus Remedies Limited | 5.91 Billion INR | 32.546% |
| Sun Pharma Advanced Research Company Limited | 755.45 Million INR | -428.102% |
| Alpa Laboratories Limited | 1.08 Billion INR | -266.893% |
| Nectar Lifesciences Limited | 16.84 Billion INR | 76.31% |
| Shilpa Medicare Limited | 11.51 Billion INR | 65.356% |
| Aarti Drugs Limited | 25.28 Billion INR | 84.222% |
| Lupin Limited | 200.1 Billion INR | 98.006% |
| Aurobindo Pharma Limited | 287.04 Billion INR | 98.61% |
| Zydus Lifesciences Limited | 190.21 Billion INR | 97.903% |
| Windlas Biotech Limited | 6.3 Billion INR | 36.77% |
| Suven Life Sciences Limited | 116.92 Million INR | -3311.952% |
| Eris Lifesciences Limited | 20.09 Billion INR | 80.143% |
| Valiant Laboratories Limited | 1.82 Billion INR | -119.138% |
| J. B. Chemicals & Pharmaceuticals Limited | 34.84 Billion INR | 88.55% |
| Solara Active Pharma Sciences Limited | 12.38 Billion INR | 67.784% |
| Ipca Laboratories Limited | 76.22 Billion INR | 94.766% |
| Bliss GVS Pharma Limited | 7.7 Billion INR | 48.204% |
| Achyut Healthcare Limited | 61.36 Million INR | -6400.939% |
| Sun Pharmaceutical Industries Limited | 484.96 Billion INR | 99.177% |
| Bajaj HealthCare Limited | 4.73 Billion INR | 15.729% |
| RPG Life Sciences Limited | 5.82 Billion INR | 31.457% |
| Mankind Pharma Limited | 103.34 Billion INR | 96.14% |
| Laurus Labs Limited | 50.01 Billion INR | 92.024% |
| Piramal Pharma Limited | 81.71 Billion INR | 95.118% |
| Syncom Formulations (India) Limited | 2.59 Billion INR | -53.892% |
| Torrent Pharmaceuticals Limited | 106.05 Billion INR | 96.238% |
| Alembic Pharmaceuticals Limited | 61.12 Billion INR | 93.473% |
| Glenmark Pharmaceuticals Limited | 118.13 Billion INR | 96.623% |
| Unichem Laboratories Limited | 16.57 Billion INR | 75.929% |
| Sequent Scientific Limited | 13.69 Billion INR | 70.873% |
| Novartis India Limited | 3.35 Billion INR | -19.066% |
| Wanbury Limited | 5.75 Billion INR | 30.695% |
| Suven Pharmaceuticals Limited | 10.51 Billion INR | 62.053% |
| Wockhardt Limited | 27.89 Billion INR | 85.695% |
| Themis Medicare Limited | 3.81 Billion INR | -4.504% |
| Jagsonpal Pharmaceuticals Limited | 2.08 Billion INR | -91.161% |
| Jubilant Pharmova Limited | 67.02 Billion INR | 94.048% |
| Glenmark Life Sciences Limited | 22.83 Billion INR | 82.527% |
| Dr. Reddy's Laboratories Limited | 279.16 Billion INR | 98.571% |
| Divi's Laboratories Limited | 78.45 Billion INR | 94.915% |
| NATCO Pharma Limited | 40.02 Billion INR | 90.031% |
| Gufic Biosciences Limited | 8.06 Billion INR | 50.543% |
| IOL Chemicals and Pharmaceuticals Limited | 21.18 Billion INR | 81.172% |
| Ind-Swift Limited | 5.02 Billion INR | 20.601% |
| Procter & Gamble Health Limited | 11.51 Billion INR | 65.346% |
| FDC Limited | 19.42 Billion INR | 79.466% |
| Krebs Biochemicals & Industries Limited | 504.21 Million INR | -691.242% |
| Granules India Limited | 45.06 Billion INR | 91.147% |
| Medicamen Biotech Limited | 1.79 Billion INR | -122.5% |
| Alkem Laboratories Limited | 126.67 Billion INR | 96.851% |
| AstraZeneca Pharma India Limited | 12.95 Billion INR | 69.205% |
| Biofil Chemicals and Pharmaceuticals Limited | 400.35 Million INR | -896.511% |
| Brooks Laboratories Limited | 794.86 Million INR | -401.919% |
| Megasoft Limited | 373.95 Million INR | -966.862% |
| ZIM Laboratories Limited | 3.67 Billion INR | -8.582% |
| Strides Pharma Science Limited | 40.51 Billion INR | 90.152% |
| Neuland Laboratories Limited | 15.58 Billion INR | 74.403% |
| Morepen Laboratories Limited | 17.01 Billion INR | 76.558% |
| Hikal Limited | 17.84 Billion INR | 77.645% |
| Indoco Remedies Limited | 17.89 Billion INR | 77.705% |
| Aarti Pharmalabs Limited | 18.15 Billion INR | 78.025% |
| Kilitch Drugs (India) Limited | 1.54 Billion INR | -158.437% |
| Mangalam Drugs & Organics Limited | 3.68 Billion INR | -8.237% |
| Hester Biosciences Limited | 3.04 Billion INR | -31.0% |